Microparticles for the delivery of DNA vaccines

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Immunological Reviews

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.0105-2896.2004.00153.xPMID 15233735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Vaccines

  2006cited by this paper
• Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

  2004cited by this paper
• Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.

  2003cited by this paper
• Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

  2003cited by this paper
• Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA.

  2003cited by this paper
• Microparticles as vaccine adjuvants and delivery systems

  2003cited by this paper
• Vaccination with Plasmid DNA Activates Dendritic Cells via Toll-Like Receptor 9 (TLR9) but Functions in TLR9-Deficient Mice 1

  2003cited by this paper
• Comparison of Poly(dl-Lactide-co-glycolide) and Polystyrene Microsphere Targeting to Intestinal M Cells

  2003cited by this paper
• The Effect of CTAB Concentration in Cationic PLG Microparticles on DNA Adsorption and in Vivo Performance

  2003cited by this paper
• Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

  2002cited by this paper
• A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines.

  2002cited by this paper
• Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.

  2002cited by this paper
• Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro

  2002cited by this paper
• Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.

  2002cited by this paper
• Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments

  2002cited by this paper
• The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery

  2001cited by this paper
• Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

  2001cited by this paper
• Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity.

  2001cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

  2001cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000influential reference
• Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

  2000cited by this paper
• Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice1

  2000cited by this paper
• Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.

  2000cited by this paper
• Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.

  2000cited by this paper
• Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

  2000cited by this paper
• Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.

  2000cited by this paper
• Cationic microparticles: A potent delivery system for DNA vaccines.

  2000cited by this paper
• Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.

  2000cited by this paper
• Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

  2000cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• In vivo priming by DNA injection occurs predominantly by antigen transfer.

  1999cited by this paper
• Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

  1999cited by this paper
• Electropermeabilization of skeletal muscle enhances gene transfer in vivo

  1999cited by this paper
• PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization.

  1999cited by this paper
• DNA vaccines--designer vaccines for the 21st century.

  1999cited by this paper
• Plasmid DNA Malaria Vaccine: Tissue Distribution and Safety Studies in Mice and Rabbits

  1999cited by this paper
• Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.

  1999cited by this paper
• Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

  1998cited by this paper
• Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles

  1998cited by this paper
• Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

  1998cited by this paper
• Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization

  1998cited by this paper
• Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

  1998cited by this paper
• Quantitative analysis of the immunopotency of genetically transfected dendritic cells.

  1998cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

  1998cited by this paper
• Microparticles and polymers for the mucosal delivery of vaccines.

  1998cited by this paper
• The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.

  1997cited by this paper
• DNA vaccines.

  1997cited by this paper
• Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

  1997cited by this paper
• Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

  1997cited by this paper
• Biologically erodable microspheres as potential oral drug delivery systems

  1997cited by this paper
• Contribution of CpG motifs to the immunogenicity of DNA vaccines.

  1997cited by this paper
• Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells

  1997cited by this paper
• Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

  1996cited by this paper
• The intestinal uptake of particles and the implications for drug and antigen delivery.

  1996cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• Gene vaccination with naked plasmid DNA: mechanism of CTL priming

  1996cited by this paper
• Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection

  1996cited by this paper
• Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells

  1996cited by this paper
• THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY

  1996cited by this paper
• Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

  1995cited by this paper
• Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

  1994cited by this paper
• Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.

  1993cited by this paper
• Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells.

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

  1992cited by this paper
• Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies

  1991cited by this paper
• Controlled release microparticles for vaccine development.

  1991cited by this paper
• Biodegradable microparticles as controlled release antigen delivery systems.

  1991cited by this paper
• Intestinal translocation of particulates — implications for drug and antigen delivery

  1990cited by this paper
• Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches

  1990cited by this paper
• Phagocytosis of polymer microspheres by macrophages

  1990influential reference
• Microparticles as potentially orally active immunological adjuvants.

  1989cited by this paper
• Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response.

  1989cited by this paper
• Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.

  1989cited by this paper
• Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers.

  1988influential reference
• Interaction of microspheres with blood constituents: I. Uptake of polystyrene spheres by monocytes and granulocytes and effect on immune responsiveness of lymphocytes.

  1983cited by this paper

• Micron-sized DNA-gelatin coacervates generated by ionic complexation in the presence of a nonionic polysaccharide.

  2026cites this paper
• Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review

  2023cites this paper
• Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement.

  2021cites this paper
• Elaboration of Charged Poly(Lactic-co-Glycolic Acid) Microparticles for Effective Release of Tranexamic Acid

  2020cites this paper
• Overview and Future Potential of Fast Dissolving Buccal Films as Drug Delivery System for Vaccines.

  2019cites this paper
• Luminescent silica mesoparticles for protein transduction.

  2019cites this paper
• Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities

  2018cites this paper
• 4.3 The Innate Response to Biomaterials

  2017cites this paper
• Polymeric Particles as Vaccine Delivery Systems

  2017cites this paper
• Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies.

  2017cites this paper
• Elaboration of sponge-like biodegradable cationic particles via double-emulsion solvent evaporation

  2017cites this paper
• Micro- and nanoparticulates for DNA vaccine delivery

  2016cites this paper
• Polymer-Based DNA Delivery Systems for Cancer Immunotherapy

  2016cites this paper
• Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens

  2016influential citation
• Gelatin-based nanoparticles as DNA delivery systems: Synthesis, physicochemical and biocompatible characterization.

  2015cites this paper
• Investigation of the stabilizer elimination during the washing step of charged PLGA microparticles utilizing a novel HPLC-UV-ELSD method.

  2015cites this paper
• Gold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

  2015cites this paper
• Paracoccidioides lutzii: estudo de alguns mecanismos de patogenicidade

  2015cites this paper
• Sustainable DNA release from chitosan/protein based-DNA gel particles.

  2014cites this paper
• DNA gel particles: an overview.

  2014cites this paper
• Dextran-based hydrogel microspheres obtained in w/o emulsion: preparation, characterisation and in vivo studies

  2014cites this paper
• Applications of nanoparticles for DNA based rabies vaccine.

  2014cites this paper
• Release of DNA and surfactant from gel particles: the receptor solution effect and the dehydration-hydration aspects.

  2014cites this paper
• Nanoparticles for DNA vaccine delivery.

  2014cites this paper
• Cationic Nanostructures for Vaccines

  2014cites this paper
• Nanoparticles in Medicine: Nanoparticle Engineering for Macrophage Targeting and Nanoparticles that Avoid Macrophage Recognition

  2014cites this paper
• Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease.

  2013cites this paper
• Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses.

  2013cites this paper
• An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles.

  2013cites this paper
• CENTRO UNIVERSITÁRIO DE BRASÍLIA - UniCEUB FACULDADE DE CIÊNCIAS DA EDUCAÇÃO E SAÚDE - FACES

  2013cites this paper
• Hydrolytic cationic ester microparticles for highly efficient DNA vaccine delivery.

  2013cites this paper
• Micro/Nanospheres for Gene Drug Delivery

  2013cites this paper
• In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model

  2013cites this paper
• ZEIN: NOVEL NATURAL POLYMER FOR NANOPARTICLE- AND FILM- MEDIATED GENE DELIVERY

  2013cites this paper
• Simultaneous, single-carrier delivery of antigens and immune-modulatory molecules to dendritic cells

  2013cites this paper
• Mucosal Vaccination: Opportunities and Challenges

  2013cites this paper
• Immunobioengineering Approaches Towards Combinatorial Delivery of Immune-Modulators and Antigens

  2013cites this paper
• Nanoparticle-Based Epidermal and Dermal Vaccination

  2013cites this paper
• Novel approaches toward the development of an oral post-exposure DNA vaccine for latent tuberculosis using Salmonella typhimurium ∆aroA vector

  2012cites this paper
• Fabrication and characterization of DNA-loaded zein nanospheres

  2012cites this paper
• Zwitterionic Polymers and Their Derivatives as Drug and Gene Delivery Carriers and Implantable Materials

  2012cites this paper
• Nanoparticles for transcutaneous vaccination

  2012cites this paper
• Vaccine Design and Vaccination

  2012cites this paper
• Therapeutic Strategies Based on Polymeric Microparticles

  2012cites this paper
• Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice.

  2012cites this paper
• Microcalorimetric studies of the effects of artesunate liposomes on the metabolism of Escherichia coli during growth

  2012cites this paper
• Improving Polymer-Mediated DNA Vaccine Delivery

  2011cites this paper
• Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes

  2011cites this paper
• The innate response to biomaterials

  2011cites this paper
• Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.

  2011cites this paper
• The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant

  2011cites this paper
• DNA Vaccination by Electrogene Transfer

  2011cites this paper
• ZEIN NANOSPHERES FOR GENE DELIVERY

  2011cites this paper
• Layer-by-layer self-assembly vectors for gene delivery.

  2011cites this paper
• Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11

  2011cites this paper
• Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.

  2011cites this paper
• Cyclodextrins as Smart Excipients in Polymeric Drug Delivery Systems

  2011cites this paper
• Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers

  2010cites this paper
• Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length.

  2010cites this paper
• NON-CONDENSING POLYMERIC GENE DELIVERY SYSTEMS: PRINCIPLES AND APPLICATIONS

  2010cites this paper
• Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.

  2010cites this paper
• Micro/nanoparticle adjuvants: preparation and formulation with antigens.

  2010cites this paper
• Gene expression mediated by dendrimer/DNA complexes encapsulated in biodegradable polymer microspheres

  2010cites this paper
• A Peptide-Based Platform for Displaying Antibodies to Engage T Cells

  2010cites this paper
• Development and evaluation of DNA vaccines in chickens against a wild bird H6N2 avian influenza virus from Western Australia

  2010cites this paper
• Evaluation of Parenteral Depot Insulin Formulation using PLGA and PLA Microparticles

  2009cites this paper
• Chitosan–plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies

  2009cites this paper
• Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

  2009cites this paper
• Polymeric Materials for Gene Delivery and DNA Vaccination

  2009cites this paper
• Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.

  2009cites this paper
• The immunogenicity of CpG-antigen conjugates.

  2009cites this paper
• Assembly of erodible, DNA-containing thin films on the surfaces of polymer microparticles: toward a layer-by-layer approach to the delivery of DNA to antigen-presenting cells.

  2009cites this paper
• Characterization of Nickel-Decorated PLGA Particles Anchored with a His-tagged Polycation

  2009cites this paper
• Évaluation de stratégies pour l'optimisation d'un vaccin à ADN contre le virus de la diarrhée virale bovine (BVDV)

  2009cites this paper
• BIODEGRADABLE POLYMERS FOR CONTROLLED RELEASE OF GENE DELIVERY SYSTEMS: BIODEGRADABLE POLYMERS FOR CONTROLLED RELEASE OF GENE DELIVERY SYSTEMS

  2009cites this paper
• Preparation and characterization of poly(lactic-co-glycolic acid) microparticles containing DNA molecules encoding a malaria vaccine candidate

  2009cites this paper
• Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.

  2009cites this paper
• Therapeutic nanomedicine: Polymeric nanosystems for drug and gene delivery

  2008cites this paper
• Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.

  2008cites this paper
• Vaccine protocols for enhanced immunogenicity of exogenous antigens.

  2008cites this paper
• Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine).

  2008cites this paper
• Physical characterization and in vivo evaluation of poloxamer‐based DNA vaccine formulations

  2008influential citation
• Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

  2008cites this paper
• Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods

  2008influential citation
• Particle-based vaccines for transcutaneous vaccination.

  2008cites this paper
• Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.

  2008cites this paper
• Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation

  2008cites this paper
• Stretched cavity-assisted molding of micrometer and submicrometer photopolymerized hydrogel particles.

  2008cites this paper
• Expansion of Foxp3-expressing regulatory T cells in vitro by dendritic cells modified with polymeric particles carrying a plasmid encoding interleukin-10.

  2008cites this paper
• The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.

  2007influential citation
• Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.

  2007cites this paper
• Optimization of an FaeG DNA vaccine in pigs

  2007cites this paper
• A vaccine to prevent transmission of human malaria: A long way to travel on a dusty and often bumpy road

  2007cites this paper
• Vaccines and therapeutic agents for tularemia

  2007cites this paper
• DNA vaccines: are they still just a powerful tool for the future?

  2007cites this paper
• Lokaler Gentransfer mit implantierbaren Arzneistoffträgern. Neue Wege zur Rekonstruktion von Haut- und Knochengewebe

  2007cites this paper
• Electroporation-based DNA immunisation: translation to the clinic

  2007cites this paper
• Nanostructured gene and drug delivery systems based on molecular self-assembly

  2007cites this paper
• Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity

  2007cites this paper
• Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle.

  2007cites this paper